Skip to content

Tibial Tubercle Distalisation and Accelerated Rehabilitation

Effect of Accelerated Postoperative Rehabilitation After Tibial Tubercle Distalisation: a Randomised Controlled Trial Protocol

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05854056
Enrollment
144
Registered
2023-05-11
Start date
2023-09-30
Completion date
2025-12-31
Last updated
2023-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patella Alta, Rehabilitation, Tibial Tubercle Distalisation Osteotomy

Keywords

Patella Alta, Tibial tubercle distalisation osteotomy, Accelerated rehabilitation

Brief summary

The goal of this clinical trial is to compare in distalising tibial tubercle osteotomy procedure group fast rehabilitation to traditional rehabilitation. The main questions it aims to answer are: * Will the novel accelerated rehabilitation protocol lead to faster recovery and improved functional outcome at 6, 12 and 24 weeks compared with the conservative rehabilitation protocol? * Will the complication rate be similar in both groups? Participants will be following fast rehabilitation or the traditional rehabilitation guidelines after distalising tibial tubercle osteotomy procedure according to the randomisation. Researchers will compare fast rehabilitation group to the traditional rehabilitation group to see if recovery and functional outcome is improved in fast rehabilitation group and complication rate will be similar in both groups.

Detailed description

Patella alta is a clinical condition where the patella is positioned too proximal in relation to the femoral trochlea. Such an abnormality may cause patellar instability and predispose to recurrent patellofemoral dislocations and patellofemoral pain. There are no conclusive guidelines for determining a threshold for too high positioned patella, as several different methods have been described to measure patellar height. As a surgical solution, distalising tibial tubercle osteotomy has been described to correct excessive patellar height. In the early phase of the distalising tibial tubercle osteotomy postoperative protocol, weightbearing and knee flexion are limited with a brace commonly for 4-8 weeks. The potential risks for adverse effects associated with the limitation rehabilitation protocol include a delay in regaining knee range of motion, stiffness and muscle weakness. As a result, recovery from surgery is delayed and may lead to additional procedures and long-term morbidity in knee function. This is a prospective, randomised, controlled, single-blinded, single centre trial comparing a novel accelerated rehabilitation protocol with the traditional, motion restricting rehabilitation protocol. All skeletally mature patients aged 35 years and younger, referred to as the distalising tibial tubercle osteotomy procedure group, are eligible for inclusion in the study. Patients will be randomised to either the fast rehabilitation group or the traditional rehabilitation group. Patients with patellar instability will be additionally treated with medial patellofemoral ligament reconstruction. The hypothesis of the trial is that the novel accelerated rehabilitation protocol will lead to faster recovery and improved functional outcome at 6, 12 and 24 weeks compared with the conservative rehabilitation protocol. A secondary hypothesis is that the complication rate will be similar in both groups. The study will document short-term recovery and the planned follow-up will be 3 years. After the 1-year follow-up, the trial results will be disseminated in a major peer-reviewed orthopaedic publication.

Interventions

See Arms section

PROCEDUREConservative rehabilitation protocol

See Arms section

Sponsors

Pihlajalinna Hospital, Tampere
CollaboratorUNKNOWN
Tampere University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
15 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

* Symptomatic patella alta with recurrent dislocation or subluxation. Long-lasting anterior knee pain not responding to rehabilitation.

Exclusion criteria

Radiographic: * Open growth plates * Iwano \[8\] grade III and IV changes in patellofemoral joint * Caton-Deschamps \<1.1 in MRI * PTI \>50% in MRI * High grade trochlear dysplasia General: * Refuses to participate in the study * Aged less than 15 or more than 35 years * Severe neurological, pulmonal or cardiovascular comorbidities that are contraindications for surgery * Lack of adequate co-operation * Does not adequately understand written and spoken instructions in the local language Those patients who decline to take part in the trial will be asked to join a follow-up cohort as a background population. The patients in this follow-up cohort will be treated as normal without allocation, but the follow-up questionnaires will be the same as those given to the randomly assigned population. The patients in the follow-up cohort will also be asked to provide informed written consent.

Design outcomes

Primary

MeasureTime frameDescription
The primary outcome in this study will be knee range of motion (ROM) measured at 12 weeks postoperatively.At 12 weeksA difference of 10º in full range of movement will be considered significant. The results will be measured with a long goniometer in a standardised manner.

Secondary

MeasureTime frameDescription
Secondary outcomes will be knee the Knee Injury and Osteoarthritis Outcome Score (KOOS).measured at baseline, 6, 24 and 52 weeks postoperativelyKOOS consists of 5 subscales: Pain, other Symptoms, Function in daily living, Function in sport and recreation and knee related Quality of life. The baseline score from KOOS is recorded during the physiotherapist visit.

Contacts

Primary ContactTimo Rahnel
timorahnel@yahoo.com+3725233242
Backup ContactAntti P Launonen
antti.launonen@pirha.fi+358405508210

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026